Atlas Trials

Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms

Clinical trial NCT02822053 · UNKNOWN

Trial details

NCT number
NCT02822053
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Neoplasms
Start date
2016-04-01
Primary completion
2018-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.